142 related articles for article (PubMed ID: 15726102)
1. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years.
Moss S; Thomas I; Evans A; Thomas B; Johns L;
Br J Cancer; 2005 Mar; 92(5):949-54. PubMed ID: 15726102
[TBL] [Abstract][Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance.
Johns LE; Moss SM;
J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
5. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM
Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099
[TBL] [Abstract][Full Text] [Related]
6. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
Moss S
J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
[TBL] [Abstract][Full Text] [Related]
7. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW
Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144
[TBL] [Abstract][Full Text] [Related]
8. False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial).
Johns LE; Moss SM;
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2758-64. PubMed ID: 20837718
[TBL] [Abstract][Full Text] [Related]
9. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
10. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
11. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme.
Blanks RG; Wallis MG; Moss SM
J Med Screen; 1998; 5(4):195-201. PubMed ID: 9934650
[TBL] [Abstract][Full Text] [Related]
12. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme.
Young KC; Wallis MG; Blanks RG; Moss SM
Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures.
Moss S; Waller M; Anderson TJ; Cuckle H;
Br J Cancer; 2005 Mar; 92(5):955-60. PubMed ID: 15726103
[TBL] [Abstract][Full Text] [Related]
14. Assessing the amount of unscheduled screening ("contamination") in the control arm of the UK "Age" Trial.
Kingston N; Thomas I; Johns L; Moss S;
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1132-6. PubMed ID: 20233850
[TBL] [Abstract][Full Text] [Related]
15. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
16. Results from 10 years of breast screening in Wales.
Fielder H; Rogers C; Gower-Thomas K; Monypenny I; Dallimore N; Brook D; Greening S
J Med Screen; 2001; 8(1):21-3. PubMed ID: 11373845
[TBL] [Abstract][Full Text] [Related]
17. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L;
Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727
[TBL] [Abstract][Full Text] [Related]
18. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
19. Use of two view mammography compared with one view in the detection of small invasive cancers: further results from the National Health Service breast screening programme.
Blanks RG; Moss SM; Wallis MG
J Med Screen; 1997; 4(2):98-101. PubMed ID: 9275268
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
